Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-Q, Date: 2010-08-13
Original SEC Filing: Click here

---

Webplus: BSPM/20100813/10-Q/1/000.htm SEC Original: biostar10q063010.htm
FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China

---

---

Webplus: BSPM/20100813/10-Q/2_EX-10.2/000.htm SEC Original: ex10-2.htm
LABORNTRACT Party A: Shaanxi Aoxing Pharmaceuticaldress: Chenyangzhai, Xianyang Legal Representative: Ronghua Wang Party B: Ronghua Wangdress: Shenjia Xiaoqu, Floor 21, Room 3103, Qindu District, Xiayang ID number: xxxxxxxxxxxxxxx Parties Party A and Party B (the I. Term of Employment 1.reement Part Arees to employ Party B and enter into this laborntract (the

---

---

Webplus: BSPM/20100813/10-Q/3_EX-31.1/000.htm SEC Original: ex31-1.htm
CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with

---

---

Webplus: BSPM/20100813/10-Q/4_EX-31.2/000.htm SEC Original: ex31-2.htm
CERTIFICATION I, Deyin Chen, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with

---

---

Webplus: BSPM/20100813/10-Q/5_EX-32.1/000.htm SEC Original: ex32-1.htm
CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 5 EX-32.1

---

---

Webplus: BSPM/20100813/10-Q/6_EX-32.2/000.htm SEC Original: ex32-2.htm
CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Deyin Chen Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 6 EX-32.2

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-Q, Date: 2010-08-13CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046